EASTPHARMA LTD.
London, 1 March 2019 - EastPharma (EAST LI) informs that it will be releasing its audited financial statements for the year ended 31 December 2018 and a review of its main subsidiary DEVA Holding's audited financial statements for the related period on 8 March 2019.
A conference call to review the financial performance for the year ended 31 December 2018 will be hosted by the management of EastPharma at 12:00-noon London time on 11 March 2019 (08:00am New York time / 01:00-pm Zurich time / 03:00pm Istanbul time). The dial-in details are provided below.
Conference call:
Dial-in Number (UK): +44 (0) 2071 928501
Dial-in Number (US): 19177200181
Dial-in Number (Switzerland): 0445806085
Dial-in Number (Germany): 030221533116
Conference ID: 4677714
For further information, please contact:
Investor Relations:
email: ir@eastpharma.com
EastPharma Ltd - a company active in the manufacturing and marketing of pharmaceutical products in Turkey and in other regional markets; for further information please visit www.eastpharma.com.